As of September 2024, Kobayashi Pharmaceutical has a market cap of $2.95B. This makes Kobayashi Pharmaceutical the world's 3994th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.14B | -11.34% |
2023 | $3.54B | -24.81% |
2022 | $4.71B | -0.11% |
2021 | $4.71B | -28.31% |
2020 | $6.58B | 36.03% |
2019 | $4.83B | 24.10% |
2018 | $3.90B | 2.05% |
2017 | $3.82B | 46.40% |
2016 | $2.61B | 0.20% |
2015 | $2.60B | 41.76% |
2014 | $1.84B | 19.93% |
2013 | $1.53B | 43.17% |
2012 | $1.07B | 1.23% |
2011 | $1.06B | 7.43% |
2010 | $983.05M | 1.34% |
2009 | $970.01M | -3.12% |
2008 | $1.00B | -8.13% |
2007 | $1.09B | -5.86% |
2006 | $1.16B | 25.78% |
2005 | $920.47M | 27.67% |
2004 | $720.99M | 6.14% |
2003 | $679.27M | -3.76% |
2002 | $705.78M | -10.77% |
2001 | $790.96M | - |